Anti-tumoural effects of cannabinoid combinations
View Patent ↗The invention relates to the use of a combination of cannabinoids, particularly tetrahydrocannabinol (THC) and cannabidiol (CBD), in the manufacture of a medicament for use in the treatment of cancer. In particular the cancer to be treated is a brain tumor, more particularly a glioma, more particularly still a glioblastoma multiforme (GBM).
1. A method for treating glioblastoma multiforme in a human in need thereof consisting essentially of administering to said human therapeutically effective amounts of cannabidiol (CBD) and tetrahydrocannabinol (THC) in combination as pure cannabinoids wherein the cannabinoids are in a ratio of from 1:1 to 1:20 (THC:CBD).
2. The method of claim 1 , wherein the treatment of the glioblastoma multiforme in a human in need thereof is to reduce cell viability, reduce cell growth or reduce tumour volume.
3. The method of claim 1 , wherein the THC and CBD are administered separately, sequentially or simultaneously to said human.